ElevenLabs is carrying a $22 billion price tag that no new investment created. The figure comes from a $300 million tender offer in which staff and existing shareholders sold vested stock, the company disclosed on Wednesday. Wellington and T. Rowe Price led the buying. Nothing was added to the balance sheet.
Key takeaways
- The $22 billion mark is a secondary-market price, set by investors buying existing ElevenLabs shares rather than funding the company.
- It is double the $11 billion the company was worth in February, and far above the $6.6 billion valuation of its first employee tender in September 2025.
- Enterprise customers supply 55% of revenue, and the ElevenAgents platform is named the single fastest-growing product.
What a tender offer actually prices
Tender offers and funding rounds get reported with the same dollar-and-valuation grammar, but they answer different questions. A round asks what someone will pay to put capital into a business. A tender asks what someone will pay to take an existing owner's place. ElevenLabs raised $500 million at an $11 billion valuation in its February Series D, so this week's number reflects demand for stock already issued.
That distinction cuts both ways. The company gets no runway from it. But the price is also harder to dismiss as a term-sheet artifact, because buyers were not negotiating for preferred shares with downside protection β they were purchasing what employees already held.
Who bought in
Wellington and T. Rowe Price are crossover managers. Their usual behavior is to build a private position and hold it through a listing, which is why their lead role reads as a signal about an eventual IPO rather than a trade.
Six firms wrote their first checks into the company as part of the deal: EQT, Goldman Sachs, GIC, OTPP, Sapphire Ventures and BDT & MSD. They joined a holder list that already included Andreessen Horowitz, Lightspeed, ICONIQ, D.E. Shaw, Evantic, DISRUPTIVE and Alkeon. TechCrunch noted this is the second time the four-year-old company has run a secondary for staff, after a $100 million transaction at $6.6 billion a year ago.
Where the revenue actually comes from
The number that explains the repricing is 55% β the share of revenue ElevenLabs attributes to enterprise customers. A company best known for a consumer-facing text-to-speech tool now earns the majority of its money from businesses deploying voice agents against their own knowledge bases and internal systems.
ElevenLabs puts specific institutions behind that claim. By its count, five of the ten biggest technology companies run its technology in daily operations, as do five of the ten largest insurers and four of the ten largest telecom operators. Insurers and telcos are instructive targets: both run enormous call-center cost centers where a voice agent has a measurable line item to displace.
Chief executive Mati Staniszewski tied the valuation to that thesis, arguing that how AI interacts with people β not raw reasoning ability β will determine how widely it spreads, and that expressive voice agents are already being deployed by enterprises and governments. He described the tender as a way for staff to capture part of the value they built.
The competitive squeeze
Eleven v4 and v4 Turbo, released alongside the valuation news, are the company's fastest and most emotive speech models to date and lead independent benchmarks, per ElevenLabs. Its models cover more than 90 languages spoken natively by over 5.5 billion people, and a healthcare-tuned transcription model, Scribe v2 Medical, shipped recently.
The strategic argument is vertical integration: run research, product and deployment in one place, with forward-deployed engineers tuning models per customer rather than shipping an average configuration. That is a direct response to pressure from platform vendors. Google's latest voice models stream audio while they reason and arrived at lower prices, which makes undifferentiated speech synthesis a commodity and pushes independents toward deployment services.
Outlook
ElevenLabs raised its first round in 2022 at a $9 million valuation. Four years on it sits at $22 billion, with headquarters split between New York and London and, by TechCrunch's framing, a place among Europe's most valuable startups. The recurring secondaries are best read as a labor-market instrument: in a market where rivals recruit with liquidity, letting staff sell is a retention cost, not a milestone. Whether AI agent revenue compounds fast enough to vindicate a price set entirely by share buyers is the open question.
FAQ
Did ElevenLabs raise new money at a $22 billion valuation?
No. The valuation was set by a $300 million tender offer, a transaction in which employees and existing shareholders sell vested shares to incoming investors. No capital reached the company's balance sheet, which makes this a secondary-market price rather than a priced round.
Who led the ElevenLabs tender offer?
Wellington and T. Rowe Price led it. Six investors participated for the first time β EQT, Goldman Sachs, GIC, OTPP, Sapphire Ventures and BDT & MSD β alongside earlier backers such as Andreessen Horowitz, Lightspeed, ICONIQ and D.E. Shaw.
How much of ElevenLabs revenue is enterprise?
The company puts it at 55%, driven mainly by ElevenAgents, its conversational agent platform. It claims production deployments inside five of the ten largest technology firms, five of the ten largest insurers and four of the ten largest telecom operators.
